Orencia Bristol-Myers Squibb Company - Treatment for Rheumatoid Arthritis

Orencia is a selective costimulation modulator, which inhibits T cell (T lymphocyte) activation. Orencia is indicated for the treatment of rheumatoid arthritis (RA).

Posted: December 2005

Related Articles:

Orencia (abatacept) FDA Approval History

View comments

Hide
(web3)